Name: ABSA’s 1st Biosecurity Symposium
Start: 2021-04-20T00:00:00-05:00
End: 2021-04-23T23:59:59-05:00
Location: Renaissance Depot Hotel

How Putin Borrowed a Page From Assad’s Chemical Weapon Playbook

2nd Case of Possible Remission of HIV-1 Reported in London

Henry Eigelsbach, Microbiologist Known for Tularemia Research, Dies at 100

by Global Biodefense Staff December 17, 2019, 10:01 am
Non-Medical Obstacles Impacting Public Health Responses

by Jennifer Osetek, PhD March 18, 2019, 10:17 am
‘TIS the Way to Transport a Highly Contagious Patient by Air

by Global Biodefense Staff March 15, 2019, 11:30 am
Why Ebola Vaccine on Trial in DRC is Raising Hopes

by Shirin Ashraf and Arthur Wickenhagen, University of Glasgow February 10, 2019, 11:21 pm
New Vaccine Manufacturing Innovation Centre Bolsters UK Pandemic Preparedness

by Global Biodefense Staff January 22, 2019, 3:00 am
BARDA Looks to Expand Clinical Studies Network for Biodefense Countermeasures

by Global Biodefense Staff January 14, 2019, 8:00 am
‘One Health’ Keeps Humans One Step Ahead of the Microbes

by Arinjay Banerjee, Karen Mossman, and Kaushal Baid December 20, 2018, 3:52 pm
The Role of Dental Professionals in Bioterrorism Response

by Global Biodefense Staff November 11, 2018, 7:35 am
Current Progress and Future Opportunities in Applications of Bioinformatics for Biodefense

by Global Biodefense Staff November 11, 2018, 6:28 am
Two Vaccines Against H7N9 Influenza Viruses Show Safety and Immunogenicity in Ferrets

by Global Biodefense Staff November 11, 2018, 5:33 am
Newsletter

Global Biodefense News

First Name

Last Name

Organization Type

Email address:

Don't worry, we don't spam
UK Contributes £5.1M to Uganda for Ebola Preparedness and Prevention

by Global Biodefense Staff November 8, 2018, 11:30 am
Most Know Kids Can Die From Flu, Yet Many Still Haven’t Had Children Vaccinated

by Global Biodefense Staff November 8, 2018, 8:42 am
Multidomain Antibody to Neutralize Flu Virus Through Entire Season

by Global Biodefense Staff November 6, 2018, 7:40 am
Next Global Malaria Threat Will Happen in Malaysia

by Global Biodefense Staff November 6, 2018, 6:20 am

Congratulations. You've reached the end of the internet.

Featured News

How Putin Borrowed a Page From Assad’s Chemical Weapon Playbook

2nd Case of Possible Remission of HIV-1 Reported in London

Henry Eigelsbach, Microbiologist Known for Tularemia Research, Dies at 100

Non-Medical Obstacles Impacting Public Health Responses

‘TIS the Way to Transport a Highly Contagious Patient by Air

Why Ebola Vaccine on Trial in DRC is Raising Hopes

New Vaccine Manufacturing Innovation Centre Bolsters UK Pandemic Preparedness

BARDA Looks to Expand Clinical Studies Network for Biodefense Countermeasures

‘One Health’ Keeps Humans One Step Ahead of the Microbes

The Role of Dental Professionals in Bioterrorism Response

Current Progress and Future Opportunities in Applications of Bioinformatics for Biodefense

Two Vaccines Against H7N9 Influenza Viruses Show Safety and Immunogenicity in Ferrets

UK Contributes £5.1M to Uganda for Ebola Preparedness and Prevention

Most Know Kids Can Die From Flu, Yet Many Still Haven’t Had Children Vaccinated

Multidomain Antibody to Neutralize Flu Virus Through Entire Season

Next Global Malaria Threat Will Happen in Malaysia

Biodefense Headlines – 21 January 2021

First Cases of B.1.1.7 Variant COVID-19 Detected in Washington State

The Response Measures Database: Central Archive of COVID-19 Interventions

EU Initiative on Health Security Work Programme 2021

Rapid Identification of Ricin in Serum Samples Using LC–MS/MS

Dr. Fauci Makes First Appearance at Biden White House Press Briefing – Transcript

ASM Expresses Support for the Global Health Security Act of 2021

How and When Will Lower-Income Countries Gain Access to COVID-19 Vaccines?

OHDSI Awarded $10M FDA Contract to Monitor Safety and Effectiveness of Vaccines, Biologics

Neutralizing Norovirus: NIAID Monoclonal Antibodies Licensing Opportunity

NIAID Looks Ahead to Pan-Coronavirus Vaccine Candidates

DRIVE ReDIRECT: Program Seeks to Develop Countermeasures Against Chemical Threats

Emerging Infections Network – Managing Travelers Who Acquire Disease Abroad

Upcoming Events

Application Deadline: Expanding Existing Research Grants, CRADAs for Novel Coronavirus Response

Envisioning a Transformed Clinical Trials Enterprise for 2030 – Session 2

Systematizing the One Health Approach in Preparedness and Response Efforts for Infectious Disease Outbreaks

Envisioning a Transformed Clinical Trials Enterprise for 2030 – Session 3

ABSA’s 1st Biosecurity Symposium

Latest Articles

More Featured News